Lupin 2024

over-the-counter medications

Year of opportunity for OTC medicines

Year of opportunity for OTC medicines

The past year has brought much change, perhaps most evident in the recent national and local elections. As we welcome a new American president and Congress, the country is waiting to see how the regulatory and legislative landscape will evolve. But I am certain that one thing will not change: the continued importance of over-the-counter

Switches will continue to be pacesetters in O-T-C arena

Switches will continue to be pacesetters in O-T-C arena

PARSIPPANY, N.J. — Growth of the U.S. over-the-counter medications market has been primarily driven by prescription-to-OTC switches And that expansion is likely to continue. Due to an increasingly favorable regulatory environment, Kline & Co., a consulting and research firm, forecasts robust prescription-to-OTC switch activity over the next five years with several new OTC categories emerging

PP_1170x120_10-25-21